Vendor ID,measureId,title,description,NQS Domain,Numerator,Denominator,Denominator Exclusions,Denominator Exceptions,Numerator Exclusions,Number of performance rates to be  submitted,"Indicate an Overall Performance Rate if more than 1 performance rate is to be submitted.                                        Specify which of the submitted rates will represent an overall performance rate for the measure or how an overall performance rate could be calculated based on the data submitted [for example, simple average of the performance rates submitted or weighted average (sum of the numerators divided by the sum of the denominators), etc.]                                                           (REQUIRED)",measureType,High Priority,Outcome,Inverse Measure,"Proportional Measure 
",Continuous Variable Measure,Ratio Measure,Is the Measure Risk-Adjusted,Primary Steward,nqfId,firstPerformanceYear
9752492,PP1,Annual Monitoring for Patients on Persistent Medications (MPM),"This measure assesses the percentage of patients 18 years of age and older who received a least 180 treatment days of ambulatory medication therapy for a select therapeutic agent during the measurement year and at least one therapeutic monitoring event for the therapeutic agent in the measurement year. Report the following three rates and a total rate:
Rate 1: Annual Monitoring for patients on angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARB): At least one serum potassium and a serum creatinine therapeutic monitoring test in the measurement year. 
Rate 2: Annual monitoring for patients on digoxin: At least one serum potassium, one serum creatinine and a serum digoxin therapeutic monitoring test in the measurement year.
Rate 3: Annual monitoring for patients on diuretics: At least one serum potassium and a serum creatinine therapeutic monitoring test in the measurement year. 
",Patient Safety,"This measure is reported as three rates and a total rate. 
Rate 1: Annual monitoring for patients on ACE inhibitors or ARBs: the number of patients with at least one serum potassium and serum creatinine therapeutic monitoring test in the measurement year.
Rate 2: Annual monitoring for patients on digoxin: the number of patients with at least one serum potassium, one serum creatinine, and a serum digoxin therapeutic monitoring test in the measurement year.
Rate 3: Annual monitoring for patients on diuretics: the number of patients with at least one serum potassium and serum creatinine therapeutic monitoring test in the measurement year.
Total rate: sum of the 3 numerators.","Patients age 18 and older as of the end of the measurement year (e.g., December 31) who are on selected persistent medications (ACE Inhibitors/ARB, Digoxin or Diuretics.)",Inpatient encounters only.,Not yet defined; Unspecified,Not yet defined; unspecified,3,Weighted Average,Process,High Priority,N/A,N,Y,N,N,N,PsychPRO,2371,2017
2786722,PP2,Follow-Up After Hospitalization for Schizophrenia (7- and 30-day),"The percentage of discharges for individuals 18 – 85 years of age who were hospitalized for treatment of schizophrenia and who had an outpatient visit, an intensive outpatient encounter or partial hospitalization with a mental health practitioner. Two rates are reported.
Rate 1: The percentage of individuals who received follow-up within 30 days of discharge
Rate 2: The percentage of individuals who received follow-up within 7 days of discharge",Communication and Care Coordination,"30-Day Follow-Up: An outpatient visit, intensive outpatient encounter or partial hospitalization with a mental health practitioner within 30 days after discharge. Include outpatient visits, intensive outpatient encounters or partial hospitalizations that occur on the date of discharge.
7-Day Follow-Up: An outpatient visit, intensive outpatient encounter or partial hospitalization with a mental health practitioner within 7 days after discharge. Include outpatient visits, intensive outpatient encounters or partial hospitalizations that occur on the date of discharge.","Adults 18 – 85 years of age of December 31 of the measurement year
Discharged alive from an acute inpatient setting (including acute care psychiatric facilities) with a principal schizophrenia diagnosis.","Non-mental health or Schizophrenia readmission or direct transfer. 
-If the discharge is followed by readmission or direct transfer within the follow-up period, count only the readmission discharge or the discharge from the hospital to which the patient was transferred.
-Exclude discharges followed by admission or direct transfer to an acute or nonacute facility within the follow-up period.",Not yet defined; Unspecified,Not yet defined; unspecified,2,Rate 1,Process,High Priority,N/A,N,Y,N,N,N,PsychPRO,N/A,2017
2786722,PP3,ADHD: Symptom Reduction in Follow up Period,"Percentage of children aged 4 through 18 years, with a diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), who demonstrated a 25% reduction in symptoms 6-12 months from baseline as measured using the Vanderbilt ADHD Diagnostic Rating Scale, regardless of treatment prescribed.",Effective Clinical Care,Children who demonstrated a 25% reduction in the mean response for either or both ADHD symptom screen subsegments 612 months from baseline assessment as measured using the Vanderbilt ADHD Diagnostic Rating Scale.,"Children aged 4 through 18 years, with a visit during the measurement period, and with an active diagnosis of ADHD, and who meet the diagnostic threshold of the Vanderbilt ADHD Diagnostic Rating Scale at the time of baseline assessment, and with baseline mean responses documented for the ADHD symptom screen subsegments for the Vanderbilt ADHD Diagnostic Rating Scale during the 6 months prior to the measurement period.",Not yet defined; Unspecified,Not yet defined; Unspecified,Not yet defined; unspecified,1,N/A,Outcome,High Priority,Outcome,N,Y,N,N,N,PsychPRO,N/A,2018
2786722,PP4,Risky Behavior Assessment or Counseling by Age 18 Years,"The percentage of adolescents with documentation of assessment or counseling for risky behavior by the age of 18 years. Four rates are reported: Rate 1: Risk Assessment or Counseling for Alcohol Use, Rate 2: Risk Assessment or Counseling for Tobacco Use, Rate 3: Risk Assessment or Counseling for Other Substance Use, and Rate 4: Risk Assessment or Counseling for Sexual Activity.",Community/Population Health,Adolescents who had documentation of a Risky Behavior Assessment or Counseling By Age 18 Years.,Adolescents with a visit who turned 18 years of age in the measurement year.,Not yet defined; Unspecified,Not yet defined; Unspecified,Not yet defined; unspecified,4,Weighted Average,Process,N/A,N/A,N,Y,N,N,N,PsychPRO,N/A,2018